{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T08:02:26Z","timestamp":1779264146735,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.cyto.2011.04.003","type":"journal-article","created":{"date-parts":[[2011,5,12]],"date-time":"2011-05-12T05:49:28Z","timestamp":1305179368000},"page":"245-250","source":"Crossref","is-referenced-by-count":33,"title":["Cytokines profile in serum of homozygous familial hypercholesterolemia is changed by LDL-apheresis"],"prefix":"10.1016","volume":"55","author":[{"given":"C.","family":"Stefanutti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vivenzio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Di Giacomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.M.","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2011.04.003_b0005","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1152\/physrev.00024.2005","article-title":"Cytokines in atherosclerosis: pathogenic and regulatory pathways","volume":"86","author":"Tedgui","year":"2006","journal-title":"Physiol Rev"},{"issue":"2","key":"10.1016\/j.cyto.2011.04.003_b0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/CS20000128","article-title":"Acute and long-term effects of low-density lipoprotein (LDL)-apheresis on oxidative damage to LDL and reducing capacity of erythrocytes in patients with severe familial hypercholesterolaemia","volume":"100","author":"Stefanutti","year":"2001","journal-title":"Clin Sci"},{"key":"10.1016\/j.cyto.2011.04.003_b0015","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/00365540310015935","article-title":"Cytokine cascade in sepsis","volume":"35","author":"Cavaillon","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.cyto.2011.04.003_b0020","doi-asserted-by":"crossref","first-page":"846","DOI":"10.4049\/jimmunol.145.3.846","article-title":"Regulation of tumor necrosis factor gene expression and protein synthesis in murine macrophages treated with recombinant tumor necrosis factor","volume":"145","author":"Descoteaux","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2011.04.003_b0025","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.4049\/jimmunol.139.6.1902","article-title":"Interleukin 1 induces interleukin 1. I. induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro","volume":"139","author":"Dinarello","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2011.04.003_b0030","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/01.CIR.0000155620.10387.43","article-title":"Resistin is an inflammatory marker of atherosclerosis in humans","volume":"111","author":"Reilly","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2011.04.003_b0035","doi-asserted-by":"crossref","first-page":"26174","DOI":"10.1074\/jbc.271.42.26174","article-title":"Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55","volume":"271","author":"Schreyer","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cyto.2011.04.003_b0040","doi-asserted-by":"crossref","first-page":"12364","DOI":"10.1074\/jbc.M111727200","article-title":"Loss of lymphotoxin-alpha but not tumor necrosis factor-alpha reduces atherosclerosis in mice","volume":"277","author":"Schreyer","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cyto.2011.04.003_b0045","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1161\/01.ATV.20.11.2394","article-title":"Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis","volume":"20","author":"Dewberry","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cyto.2011.04.003_b0050","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1172\/JCI11871","article-title":"A major role for VCAM-1, but not ICAM-1, in early atherosclerosis","volume":"107","author":"Cybulsky","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2011.04.003_b0055","doi-asserted-by":"crossref","first-page":"588","DOI":"10.4049\/jimmunol.151.2.588","article-title":"IL-4, but not tumor necrosis factor-\u03b1, increases endothelial cell adhesiveness for lymphocytes by activating a cAMP-dependent pathway","volume":"151","author":"Galea","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2011.04.003_b0060","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1006\/jmcc.2000.1278","article-title":"IL-4-induced oxidative stress upregulates VCAM-1 gene expression in human endothelial cells","volume":"33","author":"Lee","year":"2001","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.cyto.2011.04.003_b0065","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1083\/jcb.125.6.1417","article-title":"Monocyte rolling, arrest and spreading on IL-4-activated vascular endothelium under flow is mediated via sequential action of L-selectin, beta(1)-integrins, and beta(2)-integrins","volume":"125","author":"Luscinskas","year":"1994","journal-title":"J Cell Biol"},{"key":"10.1016\/j.cyto.2011.04.003_b0070","first-page":"1315","article-title":"Interleukin-4 induces the synthesis and secretion of mcp-1\/je by human endothelial cells","volume":"138","author":"Rollins","year":"1991","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cyto.2011.04.003_b0075","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1161\/hq0302.104905","article-title":"Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor\u2013\/\u2013mice","volume":"22","author":"King","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cyto.2011.04.003_b0080","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/01.ATV.19.3.611","article-title":"Expression of interleukin-10 in human atherosclerotic plaques. Relation to inducible nitric oxide synthase expression and cell death","volume":"19","author":"Mallat","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cyto.2011.04.003_b0085","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1172\/JCI118650","article-title":"Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis","volume":"97","author":"Uyemura","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2011.04.003_b0090","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1093\/ndt\/gfn127","article-title":"Protein adsorption during LDL-apheresis: proteomic analysis","volume":"23","author":"Dihazi","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.cyto.2011.04.003_b0095","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1525-1594.1996.tb04448.x","article-title":"Evaluation of double filtration plasmapheresis, thermofiltration, and low-density lipoprotein adsorptive methods by crossover test in the treatment of familial hypercholesterolemia patients","volume":"20","author":"Suzuki","year":"1996","journal-title":"Artif Organs"},{"issue":"5","key":"10.1016\/j.cyto.2011.04.003_b0100","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1161\/01.CIR.96.5.1381","article-title":"Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia","volume":"96","author":"Sampietro","year":"1997","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cyto.2011.04.003_b0105","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0021-9150(98)00152-X","article-title":"Stalenhoef AF. LPS-induced cytokine production and expression of beta2-integrins and CD14 by peripheral blood mononuclear cells of patients with homozygous familial hypercholesterolemia","volume":"141","author":"Rovers","year":"1998","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.cyto.2011.04.003_b0110","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1526-0968.2001.005001002.x","article-title":"Acute changes in plasma levels of hepatocyte growth factor during low-density lipoprotein apheresis","volume":"5","author":"Kojima","year":"2001","journal-title":"Ther Apher"},{"issue":"4","key":"10.1016\/j.cyto.2011.04.003_b0115","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/j.1526-0968.2003.00080.x","article-title":"Changes in C-reactive protein plasma levels during low-density lipoprotein apheresis","volume":"7","author":"Kojima","year":"2003","journal-title":"Ther Apher Dial"},{"issue":"3","key":"10.1016\/j.cyto.2011.04.003_b0120","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000071884","article-title":"Effects of LDL apheresis and vitamin E-modified membrane on carotid atherosclerosis in hemodialyzed patients with arteriosclerosis obliterans","volume":"26","author":"Nakamura","year":"2003","journal-title":"Kidney Blood Press Res"},{"issue":"3","key":"10.1016\/j.cyto.2011.04.003_b0125","doi-asserted-by":"crossref","first-page":"273","DOI":"10.33549\/physiolres.930460","article-title":"Selectins and monocyte chemotactic peptide as the markers of atherosclerosis activity","volume":"53","author":"Bl\u00e1ha","year":"2004","journal-title":"Physiol Res"},{"issue":"4","key":"10.1016\/j.cyto.2011.04.003_b0130","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/jca.20033","article-title":"LDL-apheresis improves peripheral arterial occlusive disease with an implication for anti-inflammatory effects","volume":"20","author":"Kobayashi","year":"2005","journal-title":"J Clin Apher"},{"issue":"1\u20132","key":"10.1016\/j.cyto.2011.04.003_b0135","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.cca.2006.09.026","article-title":"Effects of selective LDL apheresis on plasma concentrations of ICAM-1, VCAM-1 and P-selectin in diabetic patients with arteriosclerosis obliterans and receiving maintenance hemodialysis","volume":"377","author":"Utsumi","year":"2007","journal-title":"Clin Chim Acta"},{"issue":"6","key":"10.1016\/j.cyto.2011.04.003_b0140","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jca.20149","article-title":"Effects of two whole blood systems (DALI and Liposorber D) for LDL apheresis on lipids and cardiovascular risk markers in severe hypercholesterolemia","volume":"22","author":"Otto","year":"2007","journal-title":"J Clin Apher"},{"issue":"6","key":"10.1016\/j.cyto.2011.04.003_b0145","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/jca.20223","article-title":"Different inflammatory responses induced by three LDL-lowering apheresis columns","volume":"24","author":"Hovland","year":"2009","journal-title":"J Clin Apher"},{"key":"10.1016\/j.cyto.2011.04.003_b0150","doi-asserted-by":"crossref","first-page":"5590","DOI":"10.4049\/jimmunol.154.10.5590","article-title":"Administration of noncytolytic IL-10\/Fc in murine models of lipopolysaccharide-induced septic shock and allogeneic islet transplantation","volume":"154","author":"Zheng","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2011.04.003_b0155","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0041-1345(96)00412-5","article-title":"High-dose cellular IL-10 exacerbates rejection and reverses effects of cyclosporine and tacrolimus in mouse cardiac transplantation","volume":"29","author":"Li","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cyto.2011.04.003_b0160","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.4049\/jimmunol.155.8.4090","article-title":"Paradoxical effects of IL-10 in endotoxin-induced uveitis","volume":"155","author":"Rosenbaum","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2011.04.003_b0165","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1084\/jem.179.4.1379","article-title":"Production of interleukin-10 by islet cells accelerates immune-mediated destruction of \u03b2 cells in nonobese diabetic mice","volume":"179","author":"Wogensen","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2011.04.003_b0170","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/intimm\/6.12.1927","article-title":"Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice","volume":"6","author":"Moritani","year":"1994","journal-title":"Int Immunol"},{"key":"10.1016\/j.cyto.2011.04.003_b0175","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4049\/jimmunol.157.1.231","article-title":"Systemic administration of cellular IL-10 induces an effective specific and long-lived immune response against established tumor in mice","volume":"157","author":"Berman","year":"1996","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.cyto.2011.04.003_b0180","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/intimm\/11.5.689","article-title":"Paradoxical priming effects of IL-10 on cytokine production","volume":"11","author":"Adib-Conquy","year":"1996","journal-title":"Int Immunol"},{"key":"10.1016\/j.cyto.2011.04.003_b0185","first-page":"61","article-title":"Local release of interleukin-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti-inflammatory activity and results in a delayed tumor rejection","volume":"9","author":"Di Carlo","year":"1998","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.cyto.2011.04.003_b0190","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.4049\/jimmunol.154.10.5492","article-title":"A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses","volume":"154","author":"Chernoff","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2011.04.003_b0195","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1182\/blood.V87.2.699.bloodjournal872699","article-title":"Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers","volume":"87","author":"Huhn","year":"1996","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cyto.2011.04.003_b0200","first-page":"1877","article-title":"The bioactivity of Il-12: there\u2019s more to the story than P70 or P40","volume":"165","author":"Klinke","year":"2000","journal-title":"J Immunol"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466611001049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466611001049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T18:45:05Z","timestamp":1686077105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466611001049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S1043466611001049"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2011.04.003","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}